Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
Clinical trial NCT02272803 · COMPLETED
Trial details
- NCT number
- NCT02272803
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-20
- Primary completion
- 2017-02-09
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.